Home→ Research Archive→Cannabinoid Monographs
Research Archive — Cannabinoid Monographs
Cannabinoid Monographs
Each monograph is a comprehensive research reference for a single cannabinoid — compound identity, pharmacological profile, evidence by domain, and open research questions. They are written for readers who want the complete picture of one compound rather than its role in a specific health topic. The evidence tiers documented here govern how each compound is presented throughout the archive.
Cannabinoid Monographs — Complete Reference
CBC is often the fourth cannabinoid named after CBG, CBD, and CBN — and the one with the most modest research portfolio. A shorter monograph is not a shortcoming; it is an accurate reflection of where the science stands.
Research Article · Monographs
A comprehensive research reference for cannabidiol — mechanisms, evidence tiers, human trial data, and an honest accounting of what is and isn't established.
Research Article · Monographs
CBN is the most widely marketed minor cannabinoid for sleep — and the one whose reputation most substantially exceeds its current evidence base. What the pharmacology actually shows, why the sleep claim took hold, and what the controlled research has found.
Research Article · Monographs
A comprehensive research reference for cannabigerol — what it is, how it works, what the evidence shows across every domain studied, and where the gaps remain.
Experience Article · Monographs